An extension of this analysis to published datasets from a number of other cancers identified that elevated expression of HSPC111 was a feature of several cancers including those of the breast, prostate, ovary, testis, liver, colon, and pancreas [31,41], but this was not always associated with MYC over-expression. The gene discussed is MYC; the disease is cancer.